A detailed history of Xtx Topco LTD transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 84,771 shares of PYXS stock, worth $143,262. This represents 0.02% of its overall portfolio holdings.

Number of Shares
84,771
Previous 36,290 133.59%
Holding current value
$143,262
Previous $120,000 159.17%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.83 - $3.94 $137,201 - $191,015
48,481 Added 133.59%
84,771 $311,000
Q2 2024

Aug 12, 2024

SELL
$3.06 - $5.58 $90,490 - $165,011
-29,572 Reduced 44.9%
36,290 $120,000
Q1 2024

May 13, 2024

BUY
$2.03 - $6.59 $91,965 - $298,546
45,303 Added 220.36%
65,862 $280,000
Q4 2023

Feb 13, 2024

BUY
$1.4 - $2.09 $28,782 - $42,968
20,559 New
20,559 $37,000
Q2 2023

Aug 14, 2023

BUY
$2.46 - $4.07 $37,480 - $62,010
15,236 New
15,236 $39,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.